Skip to main content
. 2023 Jul 30;15(15):3882. doi: 10.3390/cancers15153882

Table 2.

Physical activity and sleep raw means.

Baseline Pre-Chemo 3 Pre-Chemo 6 6 Month Follow-Up 12 Month Follow-Up
Patients Controls Patients Controls Patients Controls Patients Controls Patients Controls
Physical Activity
MVPA a 0.55 (0.42) 1.17 (0.52) 0.74 (0.52) 1.29 (0.6) 0.64 (0.48) 1.15 (0.53) 0.85 (0.5) 1.14 (0.53) 0.71 (0.49) 1.12 (0.52)
Light Activity b 2.1 (0.66) 2.84 (0.82) 2.34 (0.8) 3.04 (0.84) 2.21 (0.84) 2.82 (0.86) 2.6 (0.62) 2.91 (0.82) 2.38 (0.81) 2.9 (0.88)
Sedentary Time c 11.88 (1.27) 11.45 (1.38) 11.68 (1.45) 11.2 (1.5) 11.73 (1.42) 11.32 (1.34) 11.26 (1.51) 11.14 (1.24) 11.79 (1.57) 11.24 (1.22)
Sleep Measures
WASO d 1.6 (0.76) 1.1 (0.56) 1.56 (0.78) 1.21 (0.73) 1.65 (0.95) 1.29 (0.73) 1.39 (0.75) 1.12 (0.64) 1.46 (0.77) 1.07 (0.62)
Sleep Efficiency e 0.79 (0.09) 0.85 (0.06) 0.8 (0.08) 0.83 (0.08) 0.8 (0.09) 0.83 (0.08) 0.82 (0.08) 0.84 (0.07) 0.81 (0.08) 0.84 (0.08)

a MVPA = moderate-to-vigorous physical activity in hours per day. b Light activity in hours per day. c Sedentary time in hours per day. d WASO = wake after sleep onset in hours per night. e Sleep efficiency, or proportion of time in bed spent asleep. Significant group differences are in bold.